Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects Of Casein Glycomacropeptide On Metabolic Control And General Health Status In Children And Adults With PKU: A Randomised Crossover Trial

NCT04076176 is registered in ClinicalTrials.gov with Vitaflo International, Ltd as lead sponsor.

NCT NCT04076176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04076176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects Of Casein Glycomacropeptide On Metabolic Control And General Health Status In Children And Adults With PKU: A Randomised Crossover Trial
Lead sponsor
Vitaflo International, Ltd
Phase
Not applicable
Overall status
Completed
Start date
April 26, 2019
Completion date
January 31, 2023
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonurias